Azilect
Rasagiline Rasagiline is a propargylamine-based medication indicated to treat Parkinson’s Disease. Status: Completed FDA Approved
-
-
Vimpat
Lacosamide Lacosamide (Vimpat) is an oral medication indicated for the treatment of partial-onset seizures. Status: Completed FDA Approved
-
Allergan
UbreIvy UbreIvy is an oral medication made for immediate treatment of migraines. Status: Completed FDA Approved
-
ACADIA
Pimavanserin Pimavanserin is indicated to treat psychosis in patients with Parkinson’s Disease. Status: Completed FDA Approved
-
Novartis
Exelon Patch The Exelon Patch is indicated for patients with mild to severe Alzheimer’s Disease to improve nerve cells function. Status: Completed FDA Approved
-
PASSAGE
Fingolimod Fingolimod (KESIMPTA) is an oral medication indicated for the treatment of relapsing multiple sclerosis. Status: Completed FDA Approved
-
PROMISE
Eptinezumab Eptinezumab (ALD403) is a CGRP antagonist for the prophylaxis of frequent episodic migraines. Status: Completed FDA Approved
-
TRIUMPH
Emgality Emgality (galcanezumab) is a preventive treatment for migraines. Status: Completed FDA Approved
-
EMBARK
Aducanumab Aducanumab is an anti-amyloid beta antibody made for patients with Alzheimer’s Disease. Status: Completed FDA Approved
